Robert Guigley is an experienced market access and strategic development leader with 15 years of experience in the biotechnology industry. He is currently Vice President of Market Access for Ambry Genetics where he leads a team of professionals partnering with regional and national health plans to manage coverage agreements and network relationships that provide access to Ambry’s testing to hundreds of millions of members nationwide. Guigley joined Ambry from innovative digital health company Omada Health, where he served as Vice President of Sales, Health Plans and Reimbursement Strategy. Before that, he held sales and market access positions at Quest Diagnostics and Counsyl, the latter of which he served as Vice President of Health Plans. Guigley earned his MBA at Boston University Questrom School of Business and his BS at the University of Pittsburgh, where he focused on economics, math and philosophy.